well-known U.S. domestic manufacturer

National Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company provides end-to-end manufacturing solutions across multiple modalities, including biologics, vaccines, nucleic acids, and cell and gene therapies. Resilience operates a network of high-tech facilities across North America, aiming to modernize the biopharmaceutical supply chain through innovative production technologies and digital integration. By offering both development and manufacturing services, the company supports partners from early-stage research through commercial-scale production.